UBASH3B and pachyonychia congenita: To investigate the relationship between UBASH3B expression levels and sensitivity to commonly used therapeutic drugs in PC, we analyzed the differences in IC50 values for eight clinically relevant drugs between high- and low-expression groups of UBASH3B.